CGH
IART icon

Crossmark Global Holdings’s Integra LifeSciences IART Stock Holding History

Crossmark Global Holdings’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-5,336
Closed -$232K – 1342
2023
Q4 		$232K Sell
5,336
-729
-12% -$28.7K ﹤0.01% 1193
2023
Q3 		$234K Sell
6,065
-214
-3% -$9K 0.01% 1133
2023
Q2 		$285K Sell
6,279
-456
-7% -$21.9K 0.01% 1093
2023
Q1 		$387K Buy
6,735
+10
+0.1% +$563 0.01% 930
2022
Q4 		$377K Sell
6,725
-427
-6% -$21.7K 0.01% 920
2022
Q3 		$303K Sell
7,152
-100
-1% -$5.12K 0.01% 989
2022
Q2 		$392K Sell
7,252
-250
-3% -$15K 0.01% 921
2022
Q1 		$482K Buy
7,502
+190
+3% +$12.5K 0.01% 913
2021
Q4 		$490K Buy
7,312
+780
+12% +$52.8K 0.01% 903
2021
Q3 		$447K Buy
6,532
+20
+0.3% +$1.41K 0.01% 977
2021
Q2 		$444K Buy
6,512
+330
+5% +$23.3K 0.01% 989
2021
Q1 		$427K Hold
6,182
– – 0.01% 983
2020
Q4 		$401K Sell
6,182
-180
-3% -$9.69K 0.01% 945
2020
Q3 		$300K Sell
6,362
-20
-0.3% -$951 0.01% 1029
2020
Q2 		$300K Sell
6,382
-48
-0.7% -$2.36K 0.01% 1012
2020
Q1 		$287K Sell
6,430
-30
-0.5% -$1.57K 0.01% 875
2019
Q4 		$376K Sell
6,460
-2,270
-26% -$135K 0.01% 982
2019
Q3 		$524K Sell
8,730
-460
-5% -$27.4K 0.02% 770
2019
Q2 		$513K Sell
9,190
-210
-2% -$10.8K 0.01% 796
2019
Q1 		$524K Buy
9,400
+60
+0.6% +$3.06K 0.01% 789
2018
Q4 		$421K Buy
9,340
+1,990
+27% +$109K 0.01% 852
2018
Q3 		$484K Buy
7,350
+70
+1% +$4.35K 0.01% 975
2018
Q2 		$469K Sell
7,280
-2,630
-27% -$163K 0.01% 992
2018
Q1 		$548K Sell
9,910
-2,520
-20% -$132K 0.01% 858
2017
Q4 		$595K Buy
12,430
+160
+1% +$7.83K 0.01% 866
2017
Q3 		$619K Buy
+12,270
New +$630K 0.02% 828
2016
Q3 		$619K Buy
+24,540
New +$1.03M 0.02% 828

Other funds holding IART

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Crossmark Global Holdings's IART Position: Q1 2024 in Review

Crossmark Global Holdings sold out of Integra LifeSciences (IART) in Q1 2024, closing a stake of 5,336 shares — an estimated $232K sold.

Crossmark Global Holdings first reported a position in IART in Q3 2016 and held it in 27 quarters. The position peaked at $619K in Q3 2017. 281 funds tracked by Wall St. Rank hold IART as of Q1 2024.

  • Crossmark Global Holdings reported no remaining Integra LifeSciences position as of Q1 2024 after selling out during the quarter.
  • Crossmark Global Holdings sold 5,336 Integra LifeSciences shares in Q1 2024, an estimated $232K.
  • Crossmark Global Holdings first reported a position in Integra LifeSciences in Q3 2016 and held it in 27 quarters.
  • Crossmark Global Holdings's Integra LifeSciences position peaked at $619K in Q3 2017.
  • 281 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2024.

Based on Crossmark Global Holdings's 13F filing for Q1 2024, filed 13 May 2024.